Comment on Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066

Detalles Bibliográficos
Autor principal: Davison, Glen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819963/
https://www.ncbi.nlm.nih.gov/pubmed/36612951
http://dx.doi.org/10.3390/ijerph20010630
_version_ 1784865356951584768
author Davison, Glen
author_facet Davison, Glen
author_sort Davison, Glen
collection PubMed
description
format Online
Article
Text
id pubmed-9819963
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98199632023-01-07 Comment on Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066 Davison, Glen Int J Environ Res Public Health Comment MDPI 2022-12-30 /pmc/articles/PMC9819963/ /pubmed/36612951 http://dx.doi.org/10.3390/ijerph20010630 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Comment
Davison, Glen
Comment on Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066
title Comment on Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066
title_full Comment on Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066
title_fullStr Comment on Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066
title_full_unstemmed Comment on Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066
title_short Comment on Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066
title_sort comment on huijghebaert et al. does trypsin oral spray (viruprotect(®)/coldzyme(®)) protect against covid-19 and common colds or induce mutation? caveats in medical device regulations in the european union. int. j. environ. res. public health 2021, 18, 5066
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819963/
https://www.ncbi.nlm.nih.gov/pubmed/36612951
http://dx.doi.org/10.3390/ijerph20010630
work_keys_str_mv AT davisonglen commentonhuijghebaertetaldoestrypsinoralsprayviruprotectcoldzymeprotectagainstcovid19andcommoncoldsorinducemutationcaveatsinmedicaldeviceregulationsintheeuropeanunionintjenvironrespublichealth2021185066

Ejemplares similares